American Heart Journal
Volume 154, Issue 1 , Pages 61.e1-61.e8 , July 2007

Timing of ischemic onset estimated from the electrocardiogram is better than historical timing for predicting outcome after reperfusion therapy for acute anterior myocardial infarction: A DANish trial in Acute Myocardial Infarction 2 (DANAMI-2) substudy

  • Maria Sejersten, MD

      Affiliations

    • Department of Cardiology, The Heart Centre, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark
    • Corresponding Author InformationReprint requests: Dr Maria Sejersten, Department of Cardiology 2142, Rigshospitalet, Copenhagen University Hospital, Blegdamsvej 9, 2100 Copenhagen Ø, Denmark.
    • ,
  • Rasmus S. Ripa, MD

      Affiliations

    • Department of Cardiology, The Heart Centre, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark
    • ,
  • Charles Maynard, PhD

      Affiliations

    • Department of Health Services, University of Washington, Seattle, WA
    • ,
  • Peer Grande, MD

      Affiliations

    • Department of Cardiology, The Heart Centre, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark
    • ,
  • Henning Rud Andersen, MD, DMSc

      Affiliations

    • Department of Cardiology, Skejby University Hospital, Aarhus, Denmark
    • ,
  • Galen S. Wagner, MD

      Affiliations

    • Duke Clinical Research Institute, Durham, NC
    • ,
  • Peter Clemmensen, MD, DMSc

      Affiliations

    • Department of Cardiology, The Heart Centre, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark
    • ,
  • for the DANAMI-2 investigators

Received 18 January 2007 ,Accepted 1 April 2007.

References 

  1. Videbaek J, Madsen M. 2004 HjerteStatistik. 1st. ed. København, Denmark: Hjerteforeningen i samarbejde med Statens Institut for Folkesundhed; 2004;
  2. Boersma E, Maas AC, Deckers JW, et al. Early thrombolytic treatment in acute myocardial infarction: reappraisal of the golden hour. Lancet. 1996;348:771–775
  3. De Luca G, Suryapranata H, Ottervanger JP, et al. Time delay to treatment and mortality in primary angioplasty for acute myocardial infarction: every minute of delay counts. Circulation. 2004;109:1223–1225
  4. Antman EM, Anbe DT, Armstrong PW, et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients with Acute Myocardial Infarction). Circulation. 2004;110:e82–e292
  5. Van de Werf F, Ardissino D, Betriu A, et al. Management of acute myocardial infarction in patients presenting with ST-segment elevation. The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology. Eur Heart J. 2003;24:28–66
  6. Nallamothu BK, Bates ER, Herrin J, et al. Times to treatment in transfer patients undergoing primary percutaneous coronary intervention in the United States: National Registry of Myocardial Infarction (NRMI)-3/4 analysis. Circulation. 2005;111:761–767
  7. Bradley EH, Herrin J, Wang Y, et al. Strategies for reducing the door-to-balloon time in acute myocardial infarction. N Engl J Med. 2006;355:2308–2320
  8. Anderson ST, Wilkins M, Weaver WD, et al. Electrocardiographic phasing of acute myocardial infarction. J Electrocardiol. 1992;25(Suppl):3–5
  9. Wilkins ML, Pryor AD, Maynard C, et al. An electrocardiographic acuteness score for quantifying the timing of a myocardial infarction to guide decisions regarding reperfusion therapy. Am J Cardiol. 1995;75:617–620
  10. Corey KE, Maynard C, Pahlm O, et al. Combined historical and electrocardiographic timing of acute anterior and inferior myocardial infarcts for prediction of reperfusion achievable size limitation. Am J Cardiol. 1999;83:826–831
  11. Andersen HR, Nielsen TT, Vesterlund T, et al. Danish multicenter randomized study on fibrinolytic therapy versus acute coronary angioplasty in acute myocardial infarction: rationale and design of the DANish trial in Acute Myocardial Infarction-2 (DANAMI-2). Am Heart J. 2003;146:234–241
  12. Andersen HR, Nielsen TT, Rasmussen K, et al. A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction. N Engl J Med. 2003;349:733–742
  13. Gambill CL, Wilkins ML, Haisty WK, et al. T wave amplitudes in normal populations. Variation with ECG lead, sex, and age. J Electrocardiol. 1995;28:191–197
  14. Hindman NB, Schocken DD, Widmann M, et al. Evaluation of a QRS scoring system for estimating myocardial infarct size. V. Specificity and method of application of the complete system. Am J Cardiol. 1985;55:1485–1490
  15. Heden B, Ripa R, Persson E, et al. A modified Anderson-Wilkins electrocardiographic acuteness score for anterior or inferior myocardial infarction. Am Heart J. 2003;146:797–803
  16. Aldrich HR, Wagner NB, Boswick J, et al. Use of initial ST-segment deviation for prediction of final electrocardiographic size of acute myocardial infarcts. Am J Cardiol. 1988;61:749–753
  17. Clemmensen P, Grande P, Aldrich HR, et al. Evaluation of formulas for estimating the final size of acute myocardial infarcts from quantitative ST-segment elevation on the initial standard 12-lead ECG. J Electrocardiol. 1991;24:77–83
  18. Juergens CP, Fernandes C, Hasche ET, et al. Electrocardiographic measurement of infarct size after thrombolytic therapy. J Am Coll Cardiol. 1996;27:617–624
  19. Engblom H, Wagner GS, Setser RM, et al. Quantitative clinical assessment of chronic anterior myocardial infarction with delayed enhancement magnetic resonance imaging and QRS scoring. Am Heart J. 2003;146:359–366
  20. Clemmensen P, Grande P, Saunamaki K, et al. Effect of intravenous streptokinase on the relation between initial ST-predicted size and final QRS-estimated size of acute myocardial infarcts. J Am Coll Cardiol. 1990;16:1252–1257
  21. Barbagelata A, Di M, Carli F, Califf RM, et al. Electrocardiographic infarct size assessment after thrombolysis: insights from the Acute Myocardial Infarction STudy, ADenosine (AMISTAD) trial. Am Heart J. 2005;150:659–665
  22. Vejlstrup N, Clemmensen P, Steinmetz E, et al. Blinded end point adjudication in the Danish multicenter randomized study on fibrinolytic therapy versus acute coronary angioplasty in acute myocardial infarction (DANAMI-2 trial). Heart Drug. 2003;3:127–133
  23. Schomig A, Ndrepepa G, Mehilli J, et al. Therapy-dependent influence of time-to-treatment interval on myocardial salvage in patients with acute myocardial infarction treated with coronary artery stenting or thrombolysis. Circulation. 2003;108:1084–1088
  24. Zijlstra F, Patel A, Jones M, et al. Clinical characteristics and outcome of patients with early (2 h), intermediate (2-4 h) and late (4 h) presentation treated by primary coronary angioplasty or thrombolytic therapy for acute myocardial infarction. Eur Heart J. 2002;23:550–557
  25. Ripa RS, Persson E, Heden B, et al. Comparison between human and automated electrocardiographic waveform measurements for calculating the Anderson-Wilkins acuteness score in patients with acute myocardial infarction. J Electrocardiol. 2005;38:96–99

 This study was supported by travel grants from the Danish Heart Foundation.

PII: S0002-8703(07)00281-5

doi: 10.1016/j.ahj.2007.04.003

American Heart Journal
Volume 154, Issue 1 , Pages 61.e1-61.e8 , July 2007

Article Tools

* Image Usage & Resolution